# Real Time Myocardial Perfusion Echocardiography for Coronary Allograft Vasculopathy

> **NCT02880137** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 36 (actual)

## Conditions studied

- Cardiac Allograft Vasculopathy

## Interventions

- **DRUG:** Perflutren Lipid Microsphere
- **PROCEDURE:** RTMPE

## Key facts

- **NCT ID:** NCT02880137
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2018-06
- **Final completion:** 2018-06-30
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2019-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02880137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02880137, "Real Time Myocardial Perfusion Echocardiography for Coronary Allograft Vasculopathy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02880137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*